Ken Griffin
MDCX

Ken Griffin’s Medicus Pharma MDCX Stock Holding History

Ken Griffin’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.18K Buy
+17,824
New +$18.6K ﹤0.01% 12781
2025
Q3 		– Sell
-41,099
Closed -$123K – 14472
2025
Q2 		$123K Buy
+41,099
New +$164K ﹤0.01% 11143

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Ken Griffin's MDCX Position: Q1 2026 in Review

Ken Griffin opened a new position in Medicus Pharma (MDCX) in Q1 2026: 17,824 shares worth $8.18K. The stake represents ﹤0.01% of the portfolio and ranks #12781 among its holdings. This is a return to the name: Ken Griffin previously reported a position in MDCX as recently as Q2 2025.

Ken Griffin first reported a position in MDCX in Q2 2025 and has held it in 2 quarters since. The position peaked at $123K in Q2 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

  • Ken Griffin held 17,824 shares of Medicus Pharma worth $8.18K as of Q1 2026.
  • Medicus Pharma was a new Ken Griffin position in Q1 2026.
  • Medicus Pharma made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12781 holding.
  • Ken Griffin first reported a position in Medicus Pharma in Q2 2025 and has held it in 2 quarters since.
  • Ken Griffin's Medicus Pharma position peaked at $123K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.